# Provision of Bordetella-Free Baboons for Pertussis Infection and Vaccination Studies

Canonical: https://abierto.us/opportunities/cber2026134085

- Solicitation number: CBER-2026-134085
- Notice type: Sources sought
- Status: Closed. Deadline was May 29, 2026 at 2:00 PM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: Food and Drug Administration (75F402)
- NAICS: 112990 All Other Animal Production
- Product or service code: 8820 Live Animals, Not Raised for Food
- Place of performance: Silver Spring, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Silver Spring. https://abierto.us/cities/silver-spring-md-2472450
- First posted: May 21, 2026
- Last posted: May 21, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/2f2aa285dfd4434588016d4c39b6b1f4/view

## Description

Pertussis is an acute, highly contagious, potentially life-threatening respiratory disease, caused by the Gram-negative bacterium Bordetella pertussis. The underlying factors leading to the failure of public health measures to control pertussis disease using currently licensed vaccines are poorly understood. A more complete understanding of this disease and of the mechanisms of vaccine-mediated protection is a critical public health need.

The baboon model of pertussis, developed in the laboratories of the Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), is the only animal model of pertussis that recapitulates the disease as observed in human patients.

Refinement of the baboon model to include establishment of infection by means of natural transmission will enable a more refine evaluation of the differences between the licensed acellular pertussis vaccines that fail to prevent infection and the whole cell vaccines that reduce infection. The performance of this study requires the purchase and delivery of twenty, Bordetella-free baboons.

## Publications

- May 21, 2026: Sources sought, due May 29, 2026 at 2:00 PM EDT. Notice 2f2aa285dfd4434588016d4c39b6b1f4. https://sam.gov/workspace/contract/opp/2f2aa285dfd4434588016d4c39b6b1f4/view

## Points of contact

- David Kramer, david.kramer@fda.hhs.gov
- Nick Sartain, nick.sartain@fda.hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/cber2026134085.